India grants Pfizer patent for pneumonia vaccine !

India has granted US pharmaceutical company Pfizer Inc. a patent for its pneumonia vaccine Prevnar 13, in spite of opposition from the health group Médecins Sans Frontières (MSF). The non-profit group had filed a “patent opposition” to prevent Pfizer from getting a patent on its pneumococcal conjugate vaccine (PCV 13). While the approval comes almost [...]

By |2017-09-16T13:32:08+05:30August 23rd, 2017|India, Patent|0 Comments

How Biocon’s profit hit by loss of intellectual properly licensing income?

As reported by Mint, Biocon revenue up 16% but profit hit by loss of licensing. Licensing is surely important source of revenue generation. Biocon’s net profit has declined which is due to loss of licensing income from Pfizer, Divestment of Axicorp stake and licensing income from other partners such as Mylan Inc. Biocon and [...]

By |2017-09-07T13:09:40+05:30April 28th, 2012|International, IP Basics|0 Comments
Go to Top